<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 03 Apr 2019 07:00:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Veterinary Oncology Licensing Agreement Signed Between SourcingLink.net and NanoSmart Pharmaceuticals, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Veterinary+Oncology+Licensing+Agreement+Signed+Between+SourcingLink.net+and+NanoSmart+Pharmaceuticals%2C+Inc./15333648.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Veterinary+Oncology+Licensing+Agreement+Signed+Between+SourcingLink.net+and+NanoSmart+Pharmaceuticals%2C+Inc./15333648.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Veterinary+Oncology+Licensing+Agreement+Signed+Between+SourcingLink.net+and+NanoSmart+Pharmaceuticals%2C+Inc./15333648.html</guid>
   <pubDate>Wed, 03 Apr 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>Veterinary Oncology Licensing Agreement Signed Between SourcingLink.net and NanoSmart Pharmaceuticals, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/Veterinary+Oncology+Licensing+Agreement+Signed+Between+SourcingLink.net+and+NanoSmart+Pharmaceuticals%2C+Inc./15333648.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Veterinary+Oncology+Licensing+Agreement+Signed+Between+SourcingLink.net+and+NanoSmart+Pharmaceuticals%2C+Inc./15333648.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Veterinary+Oncology+Licensing+Agreement+Signed+Between+SourcingLink.net+and+NanoSmart+Pharmaceuticals%2C+Inc./15333648.html</guid>
   <pubDate>Wed, 03 Apr 2019 07:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net Enters into an Exclusive Worldwide Licensing Agreement with NanoSmart Pharmaceuticals for Anti-Nuclear Antibody (ANA)-Targeted Doxorubicin Formulations to Treat Cancer</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+Enters+into+an+Exclusive+Worldwide+Licensing+Agreement+with+NanoSmart+Pharmaceuticals+for+Anti-Nuclear+Antibody+%28ANA%29-Targeted+Doxorubicin+Formulations+to+Treat+Cancer/15291884.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+Enters+into+an+Exclusive+Worldwide+Licensing+Agreement+with+NanoSmart+Pharmaceuticals+for+Anti-Nuclear+Antibody+%28ANA%29-Targeted+Doxorubicin+Formulations+to+Treat+Cancer/15291884.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+Enters+into+an+Exclusive+Worldwide+Licensing+Agreement+with+NanoSmart+Pharmaceuticals+for+Anti-Nuclear+Antibody+%28ANA%29-Targeted+Doxorubicin+Formulations+to+Treat+Cancer/15291884.html</guid>
   <pubDate>Mon, 25 Mar 2019 07:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net Signs a Letter of Intent with NanoSmart Pharmaceuticals, Inc. for a Licensee and Co-Development Collaboration of NanoSmart&amp;apos;s Proprietary Targeted Drug Delivery System for Cancer </title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+Signs+a+Letter+of+Intent+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+a+Licensee+and+Co-Development+Collaboration+of+NanoSmart%26apos%3Bs+Proprietary+Targeted+Drug+Delivery+System+for+Cancer+/15182620.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+Signs+a+Letter+of+Intent+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+a+Licensee+and+Co-Development+Collaboration+of+NanoSmart%26apos%3Bs+Proprietary+Targeted+Drug+Delivery+System+for+Cancer+/15182620.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+Signs+a+Letter+of+Intent+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+a+Licensee+and+Co-Development+Collaboration+of+NanoSmart%26apos%3Bs+Proprietary+Targeted+Drug+Delivery+System+for+Cancer+/15182620.html</guid>
   <pubDate>Tue, 26 Feb 2019 16:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net to Investigate the Potential of Combining its Novel Autologous Immune-Therapy with Synergistic Oncology Therapies</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Investigate+the+Potential+of+Combining+its+Novel+Autologous+Immune-Therapy+with+Synergistic+Oncology+Therapies/15116478.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Investigate+the+Potential+of+Combining+its+Novel+Autologous+Immune-Therapy+with+Synergistic+Oncology+Therapies/15116478.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Investigate+the+Potential+of+Combining+its+Novel+Autologous+Immune-Therapy+with+Synergistic+Oncology+Therapies/15116478.html</guid>
   <pubDate>Tue, 12 Feb 2019 16:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net to Investigate the Potential of Combining its Novel Autologous Immune-Therapy with Synergistic Oncology Therapies</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Investigate+the+Potential+of+Combining+its+Novel+Autologous+Immune-Therapy+with+Synergistic+Oncology+Therapies/15116478.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Investigate+the+Potential+of+Combining+its+Novel+Autologous+Immune-Therapy+with+Synergistic+Oncology+Therapies/15116478.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Investigate+the+Potential+of+Combining+its+Novel+Autologous+Immune-Therapy+with+Synergistic+Oncology+Therapies/15116478.html</guid>
   <pubDate>Tue, 12 Feb 2019 16:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60001765</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net to Leverage Pharmacogenomics in Its Oncology Therapy Development and Clinical Trial Program</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Leverage+Pharmacogenomics+in+Its+Oncology+Therapy+Development+and+Clinical+Trial+Program/15080042.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Leverage+Pharmacogenomics+in+Its+Oncology+Therapy+Development+and+Clinical+Trial+Program/15080042.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+to+Leverage+Pharmacogenomics+in+Its+Oncology+Therapy+Development+and+Clinical+Trial+Program/15080042.html</guid>
   <pubDate>Tue, 05 Feb 2019 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net Plans to Use &amp;apos;Game Changing&amp;apos; Diagnostic Tool in its R&amp;amp;D and Beyond</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+Plans+to+Use+%26apos%3BGame+Changing%26apos%3B+Diagnostic+Tool+in+its+R%26amp%3BD+and+Beyond/15048540.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+Plans+to+Use+%26apos%3BGame+Changing%26apos%3B+Diagnostic+Tool+in+its+R%26amp%3BD+and+Beyond/15048540.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+Plans+to+Use+%26apos%3BGame+Changing%26apos%3B+Diagnostic+Tool+in+its+R%26amp%3BD+and+Beyond/15048540.html</guid>
   <pubDate>Mon, 28 Jan 2019 21:31:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net Licenses an Immune-Cell Therapy in Oncology from Tulynode Biosciences, Inc.</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+Licenses+an+Immune-Cell+Therapy+in+Oncology+from+Tulynode+Biosciences%2C+Inc./15029243.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+Licenses+an+Immune-Cell+Therapy+in+Oncology+from+Tulynode+Biosciences%2C+Inc./15029243.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+Licenses+an+Immune-Cell+Therapy+in+Oncology+from+Tulynode+Biosciences%2C+Inc./15029243.html</guid>
   <pubDate>Tue, 22 Jan 2019 21:57:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net (SNET) Update on the Lac Fire Lithium Property and Completion of 43-101 Compliant Report with Recommended Work Program</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+%28SNET%29+Update+on+the+Lac+Fire+Lithium+Property+and+Completion+of+43-101+Compliant+Report+with+Recommended+Work+Program/13999740.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+%28SNET%29+Update+on+the+Lac+Fire+Lithium+Property+and+Completion+of+43-101+Compliant+Report+with+Recommended+Work+Program/13999740.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+%28SNET%29+Update+on+the+Lac+Fire+Lithium+Property+and+Completion+of+43-101+Compliant+Report+with+Recommended+Work+Program/13999740.html</guid>
   <pubDate>Thu, 29 Mar 2018 11:23:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net Locates High Grade Lithium Mineralization during the Phase I Exploration Program on the Lac Fire Lithium Property</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+Locates+High+Grade+Lithium+Mineralization+during+the+Phase+I+Exploration+Program+on+the+Lac+Fire+Lithium+Property/13721572.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+Locates+High+Grade+Lithium+Mineralization+during+the+Phase+I+Exploration+Program+on+the+Lac+Fire+Lithium+Property/13721572.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+Locates+High+Grade+Lithium+Mineralization+during+the+Phase+I+Exploration+Program+on+the+Lac+Fire+Lithium+Property/13721572.html</guid>
   <pubDate>Thu, 25 Jan 2018 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
  <item>
   <title>SourcingLink.net Succeeds in Additional Lithium Exploration</title>
   <link>http://www.streetinsider.com/Press+Releases/SourcingLink.net+Succeeds+in+Additional+Lithium+Exploration/12988013.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/SourcingLink.net+Succeeds+in+Additional+Lithium+Exploration/12988013.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SourcingLink.net+Succeeds+in+Additional+Lithium+Exploration/12988013.html</guid>
   <pubDate>Wed, 07 Jun 2017 08:30:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">SNET</category>
   	  </item>
 </channel>
</rss>
